Table 2.
Wilcoxon signed-rank tests of clinical markers and goals
| Outcome | Baseline, Med. (Q1–Q3) | Final, Med. (Q1–Q3) | Δ, Med. (Q1–Q3) | P Value |
|---|---|---|---|---|
| Attendance | ||||
| Attendance (sessions) | — | 7 (6–7) | — | — |
| Attendance (3 mo), No. (%) | 5 (20) | |||
| Attendance of 4+ sessions, No. (%) | 22 (88) | |||
| Health outcomes | ||||
| Systolic BP, mm Hg | 132 (114–142) | 122 (118–131) | −2.0 (−12 to 8) | 0.4544 |
| Diastolic BP, mm Hg | 73.0 (67.0–78.0) | 71.5 (64.5–74.0) | −2.0 (−7.5 to 4.5) | 0.2970 |
| HbA1c, % | 7.05 (6.60–8.30) | 6.75 (6.30–7.50) | −0.275 (−1.3 to 0) | 0.0176* |
| GFR, ml/min | 35 (33–42) | 38 (32–43) | 0 (−3 to 9) | 0.1674 |
| BMI, kg/m2 | 29.0 (26.8–32.3) | 29.2 (25.6–31.6) | −0.45 (−0.8 to 0.10) | 0.0522 |
| Goal progressa | ||||
| Goals per patient | 2 (1–2) | |||
| Max goal progress, No. (%) | ||||
| Total | 51 (100) | |||
| Achieved goal | 35 (68.6) | |||
| Made progress | 15 (29.4) | |||
| Dropped goal | 1 (1.96) | |||
| Exercise and movement | 22 (43.1) | |||
| Achieved goal | 17 (77.3) | |||
| Made progress | 4 (18.2) | |||
| Dropped goal | 1 (4.55) | |||
| Food, drink, and diet | 17 (33.3) | |||
| Achieved goal | 9 (52.9) | |||
| Made progress | 8 (47.1) | |||
| Dropped goal | 0 (0.0) | |||
| Emotions and thoughts | 5 (9.8) | |||
| Achieved goal | 4 (80.0) | |||
| Made progress | 1 (20.0) | |||
| Dropped goal | 0 (0.0) | |||
| Other goalsb | 7 (13.7) | |||
| Achieved goal | 5 (71.5) | |||
| Made progress | 2 (28.6) | |||
| Dropped goal | 0 (0.0) |
BMI, body mass index; HbA1c, hemoglobin A1c.
a
We recorded the highest progress over the eight sessions, with achieved goal being the highest possible progress, followed by made progress, try again, did not address, and dropped goal.
b
Other goals included healthy behaviors (n=2), loved ones (n=1), personal growth (n=2), and sleep and rest (n=2). Patients made progress in loved ones and sleep and rest and achieved goals in all others (including for one sleep and rest goal).